What are the major opportunities in the Necrotizing Enterocolitis market? What are the strategies for the Necrotizing Enterocolitis market?

For detailed insights on the major opportunities and strategies in the Necrotizing Enterocolitis market, Read More

How does the Necrotizing Enterocolitis market relate to the overall economy and other similar markets?

For detailed insights on Necrotizing Enterocolitis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Necrotizing Enterocolitis market growth? SWOT analysis of the Necrotizing Enterocolitis market.

For detailed insights on the key dynamics influencing the Necrotizing Enterocolitis market growth and SWOT analysis of the Necrotizing Enterocolitis industry, Read More

Necrotizing Enterocolitis Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Necrotizing Enterocolitis Market Report 2026

Name: Necrotizing Enterocolitis Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment (Total Parenteral Nutrition (TPN), Gastrointestinal Decompression, Antimicrobial Therapy, Antifungal Treatment, Paracentesis, Other Treatments), By Diagnosis (Laboratory Tests, Imaging Techniques), By Stage (Stage I (Suspected Necrotizing Enterocolitis), Stage II (Definite Necrotizing Enterocolitis), Stage III (Advanced Necrotizing Enterocolitis)), By End-User (Hospitals, Neonatal Intensive Care Units (NICUs), Specialty Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Necrotizing Enterocolitis Market Overview

• Necrotizing Enterocolitis market size has reached to $5.14 billion in 2025

• Expected to grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%

• Growth Driver: Rising Cases Of Premature Births Driving Growth In The Market Due To Increasing Risk In Preterm Infants

• Market Trend: Advancements In Innovative Treatments For Necrotizing Enterocolitis In Premature Infants

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Necrotizing Enterocolitis Market?

Necrotizing enterocolitis (NEC) is a serious, potentially life-threatening gastrointestinal condition that primarily affects premature infants. It involves the inflammation and death (necrosis) of the tissue in the intestines, which can lead to perforation, infection, and other complications. The common symptoms of necrotizing enterocolitis include feeding intolerance, abdominal distension, vomiting, and changes in bowel movements.

The main treatment types of necrotizing enterocolitis are total parenteral nutrition (TPN), gastrointestinal decompression, antimicrobial therapy, antifungal treatment, paracentesis, and others. Total parenteral nutrition (TPN) delivers nutrients directly into the bloodstream, helping infants with NEC by allowing their intestines to rest and heal. It is diagnosed by various diagnoses, such as laboratory tests and imaging techniques in several different stages, including stage I (suspected necrotizing enterocolitis), stage II (definite necrotizing enterocolitis), and stage III (advanced necrotizing enterocolitis). It is distributed through various distribution channels such as direct tender, hospital pharmacy, retail pharmacy, online pharmacy, and others and is used by several end users, including hospitals, neonatal intensive care units (NICUs), and specialty clinics.

Necrotizing Enterocolitis Market Global Report 2026 Market Report bar graph

What Is The Necrotizing Enterocolitis Market Size and Share 2026?

The necrotizing enterocolitis market size has grown strongly in recent years. It will grow from $5.14 billion in 2025 to $5.47 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to high incidence of premature births, limited neonatal care infrastructure, reliance on broad-spectrum antibiotics, delayed diagnosis in low-resource settings, early development of parenteral nutrition.

What Is The Necrotizing Enterocolitis Market Growth Forecast?

The necrotizing enterocolitis market size is expected to see strong growth in the next few years. It will grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising investment in neonatal intensive care units, advancements in regenerative and stem cell therapies, increasing awareness of early nec detection, growing adoption of precision nutrition therapies, expansion of neonatal imaging innovations. Major trends in the forecast period include rising adoption of probiotics and prebiotics for nec prevention, increased focus on early diagnosis and screening in premature infants, growing utilization of individualized tpn solutions, expansion of minimally invasive surgical interventions, advancements in neonatal critical care and monitoring.

Book your 30 minutes free consultation with our research experts

Global Necrotizing Enterocolitis Market Segmentation

1) By Treatment: Total Parenteral Nutrition (TPN), Gastrointestinal Decompression, Antimicrobial Therapy, Antifungal Treatment, Paracentesis, Other Treatments

2) By Diagnosis: Laboratory Tests, Imaging Techniques

3) By Stage: Stage I (Suspected Necrotizing Enterocolitis), Stage II (Definite Necrotizing Enterocolitis), Stage III (Advanced Necrotizing Enterocolitis)

4) By End-User: Hospitals, Neonatal Intensive Care Units (NICUs), Specialty Clinics

Subsegments:

1) By Total Parenteral Nutrition (TPN): Standard TPN Formulations, Customized Or Individualized TPN Solutions, Lipid Emulsions For TPN, Protein And Amino Acid Supplements In TPN, Micronutrient And Electrolyte-Enhanced TPN

2) By Gastrointestinal Decompression: Nasogastric Tube (NG Tube) Decompression, Orogastric Tube Decompression, Surgical Gastrostomy For Decompression, Non-Surgical Decompression Techniques

3) By Antimicrobial Therapy: Broad-Spectrum Antibiotics, Gram-Positive Coverage Antibiotics, Gram-Negative Coverage Antibiotics, Combination Antibiotic Therapy, Prophylactic Antibiotic Strategies For High-Risk Neonates

4) By Antifungal Treatment: Systemic Antifungal Therapy, Prophylactic Antifungal Therapy For Preterm Infants, Combination Antifungal And Antibiotic Therapy For Severe NEC

5) By Paracentesis: Diagnostic Paracentesis, Therapeutic Paracentesis, Guided Paracentesis using Ultrasound Or Radiological Techniques

6) By Other Treatments: Probiotics And Prebiotics for NEC Prevention, Surgical Interventions, Stem Cell Therapy And Regenerative Medicine Approaches, Immunomodulatory Therapies, Supportive Care

What Is The Driver Of The Necrotizing Enterocolitis Market?

The increasing cases of premature births are expected to propel the growth of the necrotizing enterocolitis market going forward. Premature births, also known as preterm births, refer to the delivery of a baby before 37 weeks of gestation, compared to the typical 40-week pregnancy term. The increasing cases of premature births are due to maternal health conditions such as high blood pressure, diabetes, and infections, which increase the risk of preterm labor, and lifestyle factors, including smoking, drug use, and poor nutrition, contribute to a higher likelihood of premature births. Rising premature births lead to more cases of necrotizing enterocolitis (NEC) as premature infants have immature gastrointestinal systems, increasing susceptibility to inflammation and infection. For instance, in January 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, premature births account for 8.67% of total births in the United States annually. Therefore, increasing cases of premature births are driving the growth of the necrotizing enterocolitis industry.

Key Players In The Global Necrotizing Enterocolitis Market

Major companies operating in the necrotizing enterocolitis market are Abbott Laboratories, Astellas Pharma Inc., Mayo Foundation for Medical Education and Research, Cleveland Clinic, Boston Children's Hospital, Hollister Incorporated, UPMC Children's Hospital of Pittsburgh, Prolacta Bioscience Inc., Evolve BioSystems, Sigma-Tau Pharmaceuticals, Mead Johnson & Company LLC, Liminal BioSciences Inc., Noveome Biotherapeutics Inc., Infant Bacterial Therapeutics, Prometic Life Sciences Inc., Nexilico, Siolta Therapeutics, ProThera Biologics Inc., Plakous Therapeutics Inc., Chosen Diagnostics Inc.

Global Necrotizing Enterocolitis Market Trends and Insights

Major companies operating in the necrotizing enterocolitis market are focusing on developing innovative product solutions, such as cell-free sterile biologic solutions, to address the critical unmet need for effective treatments and improve outcomes in premature infants. A cell-free sterile biologic solution is a purified, sterile liquid containing bioactive molecules such as proteins, growth factors, and cytokines derived from cultured cells but without any intact cells, designed to promote healing and reduce inflammation. For instance, in December 2023, Noveome Biotherapeutics, Inc., a US-based biopharmaceutical company, received notification from the U.S. Food and Drug Administration (FDA), allowing the company to proceed with its Phase 1-2 clinical trial for ST266, a novel biologic aimed at treating necrotizing enterocolitis (NEC) in premature infants. It marks a significant milestone as ST266 is anticipated to be the first major therapeutic advancement for NEC in over 30 years, addressing a critical medical need given the disease's high morbidity and mortality rates among vulnerable populations.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Necrotizing Enterocolitis Market?

In January 2025, Siolta Therapeutics, a US-based developer of novel live biotherapeutics for necrotizing enterocolitis, partnered with Cowellnex Co. to prevent necrotizing enterocolitis (NEC) in premature infants. This collaboration aims to combine Siolta's expertise in microbial science with Cowellnex's institutional strength, leveraging Siolta's Precision Symbiotics Platform to advance research and establish treatments in microbiome drug discovery. Cowellnex Co. Ltd. is a US-based biotechnology company advancing microbiome drug discovery.

Regional Outlook

North America was the largest region in the necrotizing enterocolitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Necrotizing Enterocolitis Market?

The necrotizing enterocolitis market consists of revenues earned by entities providing services such as neonatal intensive care, nutritional support, medical monitoring and support, and parental counseling and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The necrotizing enterocolitis market also includes sales of feeding tubes, surgical instruments for resection, and anti-inflammatory drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Necrotizing Enterocolitis Market Report 2026?

The necrotizing enterocolitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the necrotizing enterocolitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Necrotizing Enterocolitis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$5.47 billion
Revenue Forecast In 2035	$6.95 billion
Growth Rate	CAGR of 6.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment, Diagnosis, Stage, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Abbott Laboratories, Astellas Pharma Inc., Mayo Foundation for Medical Education and Research, Cleveland Clinic, Boston Children's Hospital, Hollister Incorporated, UPMC Children's Hospital of Pittsburgh, Prolacta Bioscience Inc., Evolve BioSystems, Sigma-Tau Pharmaceuticals, Mead Johnson & Company LLC, Liminal BioSciences Inc., Noveome Biotherapeutics Inc., Infant Bacterial Therapeutics, Prometic Life Sciences Inc., Nexilico, Siolta Therapeutics, ProThera Biologics Inc., Plakous Therapeutics Inc., Chosen Diagnostics Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Necrotizing Enterocolitis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Necrotizing Enterocolitis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Necrotizing Enterocolitis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Necrotizing Enterocolitis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Adoption Of Probiotics And Prebiotics For Nec Prevention

4.2.2 Increased Focus On Early Diagnosis And Screening In Premature Infants

4.2.3 Growing Utilization Of Individualized Tpn Solutions

4.2.4 Expansion Of Minimally Invasive Surgical Interventions

4.2.5 Advancements In Neonatal Critical Care And Monitoring

5. Necrotizing Enterocolitis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Neonatal Intensive Care Units (Nicus)

5.3 Specialty Clinics

5.4 Pediatric Care Centers

5.5 Research & Academic Institutions

6. Necrotizing Enterocolitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Necrotizing Enterocolitis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Necrotizing Enterocolitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Necrotizing Enterocolitis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Necrotizing Enterocolitis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Necrotizing Enterocolitis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Necrotizing Enterocolitis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Necrotizing Enterocolitis Market Segmentation

9.1. Global Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Total Parenteral Nutrition (TPN), Gastrointestinal Decompression, Antimicrobial Therapy, Antifungal Treatment, Paracentesis, Other Treatments

9.2. Global Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Laboratory Tests, Imaging Techniques

9.3. Global Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stage I (Suspected Necrotizing Enterocolitis), Stage II (Definite Necrotizing Enterocolitis), Stage III (Advanced Necrotizing Enterocolitis)

9.4. Global Necrotizing Enterocolitis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Neonatal Intensive Care Units (NICUs), Specialty Clinics, Pediatric Care Centers

9.5. Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Total Parenteral Nutrition (TPN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard TPN Formulations, Customized Or Individualized TPN Solutions, Lipid Emulsions For TPN, Protein And Amino Acid Supplements In TPN, Micronutrient And Electrolyte-Enhanced TPN

9.6. Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Gastrointestinal Decompression, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nasogastric Tube (NG Tube) Decompression, Orogastric Tube Decompression, Surgical Gastrostomy For Decompression, Non-Surgical Decompression Techniques

9.7. Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Antimicrobial Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Broad-Spectrum Antibiotics, Gram-Positive Coverage Antibiotics, Gram-Negative Coverage Antibiotics, Combination Antibiotic Therapy, Prophylactic Antibiotic Strategies For High-Risk Neonates

9.8. Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Antifungal Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Systemic Antifungal Therapy, Prophylactic Antifungal Therapy For Preterm Infants, Combination Antifungal And Antibiotic Therapy For Severe NEC

9.9. Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Paracentesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic Paracentesis, Therapeutic Paracentesis, Guided Paracentesis using Ultrasound Or Radiological Techniques

9.10. Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Probiotics And Prebiotics for NEC Prevention, Surgical Interventions, Stem Cell Therapy And Regenerative Medicine Approaches, Immunomodulatory Therapies, Supportive Care

10. Necrotizing Enterocolitis Market Regional And Country Analysis

10.1. Global Necrotizing Enterocolitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Necrotizing Enterocolitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Necrotizing Enterocolitis Market

11.1. Asia-Pacific Necrotizing Enterocolitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Necrotizing Enterocolitis Market

12.1. China Necrotizing Enterocolitis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Necrotizing Enterocolitis Market

13.1. India Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Necrotizing Enterocolitis Market

14.1. Japan Necrotizing Enterocolitis Market Overview

14.2. Japan Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Necrotizing Enterocolitis Market

15.1. Australia Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Necrotizing Enterocolitis Market

16.1. Indonesia Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Necrotizing Enterocolitis Market

17.1. South Korea Necrotizing Enterocolitis Market Overview

17.2. South Korea Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Necrotizing Enterocolitis Market

18.1. Taiwan Necrotizing Enterocolitis Market Overview

18.2. Taiwan Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Necrotizing Enterocolitis Market

19.1. South East Asia Necrotizing Enterocolitis Market Overview

19.2. South East Asia Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Necrotizing Enterocolitis Market

20.1. Western Europe Necrotizing Enterocolitis Market Overview

20.2. Western Europe Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Necrotizing Enterocolitis Market

21.1. UK Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Necrotizing Enterocolitis Market

22.1. Germany Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Necrotizing Enterocolitis Market

23.1. France Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Necrotizing Enterocolitis Market

24.1. Italy Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Necrotizing Enterocolitis Market

25.1. Spain Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Necrotizing Enterocolitis Market

26.1. Eastern Europe Necrotizing Enterocolitis Market Overview

26.2. Eastern Europe Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Necrotizing Enterocolitis Market

27.1. Russia Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Necrotizing Enterocolitis Market

28.1. North America Necrotizing Enterocolitis Market Overview

28.2. North America Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Necrotizing Enterocolitis Market

29.1. USA Necrotizing Enterocolitis Market Overview

29.2. USA Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Necrotizing Enterocolitis Market

30.1. Canada Necrotizing Enterocolitis Market Overview

30.2. Canada Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Necrotizing Enterocolitis Market

31.1. South America Necrotizing Enterocolitis Market Overview

31.2. South America Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Necrotizing Enterocolitis Market

32.1. Brazil Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Necrotizing Enterocolitis Market

33.1. Middle East Necrotizing Enterocolitis Market Overview

33.2. Middle East Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Necrotizing Enterocolitis Market

34.1. Africa Necrotizing Enterocolitis Market Overview

34.2. Africa Necrotizing Enterocolitis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Necrotizing Enterocolitis Market Regulatory and Investment Landscape

36. Necrotizing Enterocolitis Market Competitive Landscape And Company Profiles

36.1. Necrotizing Enterocolitis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Necrotizing Enterocolitis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Necrotizing Enterocolitis Market Company Profiles

36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Cleveland Clinic Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Boston Children's Hospital Overview, Products and Services, Strategy and Financial Analysis

37. Necrotizing Enterocolitis Market Other Major And Innovative Companies

Hollister Incorporated, UPMC Children's Hospital of Pittsburgh, Prolacta Bioscience Inc., Evolve BioSystems, Sigma-Tau Pharmaceuticals, Mead Johnson & Company LLC, Liminal BioSciences Inc., Noveome Biotherapeutics Inc., Infant Bacterial Therapeutics, Prometic Life Sciences Inc., Nexilico, Siolta Therapeutics, ProThera Biologics Inc., Plakous Therapeutics Inc., Chosen Diagnostics Inc.

38. Global Necrotizing Enterocolitis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Necrotizing Enterocolitis Market

40. Necrotizing Enterocolitis Market High Potential Countries, Segments and Strategies

40.1 Necrotizing Enterocolitis Market In 2030 - Countries Offering Most New Opportunities

40.2 Necrotizing Enterocolitis Market In 2030 - Segments Offering Most New Opportunities

40.3 Necrotizing Enterocolitis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Necrotizing Enterocolitis Market, Overview Of Key Products - Product Examples

Table 2: Global Necrotizing Enterocolitis Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Necrotizing Enterocolitis Market, Supply Chain Analysis

Table 4: Global Necrotizing Enterocolitis Market, Major Raw Material Providers

Table 5: Global Necrotizing Enterocolitis Market, Major Resource Providers

Table 6: Global Necrotizing Enterocolitis Market, Major Manufacturers (Suppliers)

Table 7: Global Necrotizing Enterocolitis Market, Major Distributors And Channel Partners

Table 8: Global Necrotizing Enterocolitis Market, Key Technologies & Future Trends

Table 9: Global Necrotizing Enterocolitis Market, Major Trends

Table 10: Global Necrotizing Enterocolitis Market, Major End Users

Table 11: Global Necrotizing Enterocolitis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Necrotizing Enterocolitis Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Necrotizing Enterocolitis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Necrotizing Enterocolitis Market - TAM, US$ Billion, 2025

Table 15: Global Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Necrotizing Enterocolitis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Total Parenteral Nutrition (TPN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Gastrointestinal Decompression, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Antimicrobial Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Antifungal Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Paracentesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Necrotizing Enterocolitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Necrotizing Enterocolitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Global Necrotizing Enterocolitis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 100: Global Necrotizing Enterocolitis Market - Company Scoring Matrix

Table 101: Abbott Laboratories Financial Performance

Table 102: Astellas Pharma Inc. Financial Performance

Table 103: Mayo Foundation for Medical Education and Research Financial Performance

Table 104: Cleveland Clinic Financial Performance

Table 105: Boston Children's Hospital Financial Performance

Table 106: Global Necrotizing Enterocolitis Market, Competitive Benchmarking (In USD Billions)

Table 107: Global Necrotizing Enterocolitis Market, Competitive Dashboard

Table 108: Global Necrotizing Enterocolitis Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 109: Global, Necrotizing Enterocolitis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Table 110: Global, Necrotizing Enterocolitis Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Table 111: Global, Necrotizing Enterocolitis Market Size Gain ($ Billion), Segmentation By Stage, 2025 – 2030

List Of Figures

Figure 1: Global Necrotizing Enterocolitis Market, Overview Of Key Products - Product Examples

Figure 2: Global Necrotizing Enterocolitis Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Necrotizing Enterocolitis Market, Supply Chain Analysis

Figure 4: Global Necrotizing Enterocolitis Market, Major Raw Material Providers

Figure 5: Global Necrotizing Enterocolitis Market, Major Resource Providers

Figure 6: Global Necrotizing Enterocolitis Market, Major Manufacturers (Suppliers)

Figure 7: Global Necrotizing Enterocolitis Market, Major Distributors And Channel Partners

Figure 8: Global Necrotizing Enterocolitis Market, Key Technologies & Future Trends

Figure 9: Global Necrotizing Enterocolitis Market, Major Trends

Figure 10: Global Necrotizing Enterocolitis Market, Major End Users

Figure 11: Global Necrotizing Enterocolitis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Necrotizing Enterocolitis Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Necrotizing Enterocolitis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Necrotizing Enterocolitis Market - TAM, US$ Billion, 2025

Figure 15: Global Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Necrotizing Enterocolitis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Total Parenteral Nutrition (TPN), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Gastrointestinal Decompression, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Antimicrobial Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Antifungal Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Paracentesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Necrotizing Enterocolitis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Necrotizing Enterocolitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Necrotizing Enterocolitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Necrotizing Enterocolitis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Necrotizing Enterocolitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Necrotizing Enterocolitis Market, Segmentation By Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Global Necrotizing Enterocolitis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 100: Global Necrotizing Enterocolitis Market - Company Scoring Matrix

Figure 101: Abbott Laboratories Financial Performance

Figure 102: Astellas Pharma Inc. Financial Performance

Figure 103: Mayo Foundation for Medical Education and Research Financial Performance

Figure 104: Cleveland Clinic Financial Performance

Figure 105: Boston Children's Hospital Financial Performance

Figure 106: Global Necrotizing Enterocolitis Market, Competitive Benchmarking (In USD Billions)

Figure 107: Global Necrotizing Enterocolitis Market, Competitive Dashboard

Figure 108: Global Necrotizing Enterocolitis Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 109: Global, Necrotizing Enterocolitis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Figure 110: Global, Necrotizing Enterocolitis Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Figure 111: Global, Necrotizing Enterocolitis Market Size Gain ($ Billion), Segmentation By Stage, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Gastrointestinal Pathogen Testing Market Report 2026 - Global Outlook – By Pathogen Type (Bacteria, Viruses, Parasites), By Test Type (Molecular Tests, Culture, Biochemical Tests, Other Test Types), By Panel Type (Syndro...

Hospice Care Market Report 2026 - Global Outlook – By Type (Nursing Services, Medical Supply Services, Physician Services, Other Types), By Payer And Payment Mode (Private Health Insurance, Public And Government Programs...

Viral Gastroenteritis Market Report 2026 - Global Outlook – By Drugs (Antibiotics, Antacids, Antimotility Agents, Others Drugs), By Diagnosis (Physical Examination, Rapid Stool Test), By Indication (Watery Diarrhea, Abdo...

Hospital-Acquired Infection Control Market Report 2026 - Global Outlook – By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And...

Rotavirus Prophylaxis Market Report 2026 - Global Outlook – By Treatment (Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments), By Route of Administration (Oral, Other Route of Administrations), By Dis...

Enteral Feeding Formula Market Report 2026 - Global Outlook – By Product (Standard Formulas, Disease-Specific Formulas), By Stage (Adults, Pediatrics), By Application (Oncology, Gastroenterology, Neurology, Diabetes, Cri...

Acute Pancreatitis Market Report 2026 - Global Outlook – By Cause (Gallstones, Alcohol, Other Causes), By Treatment (Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERC...

Frequently Asked Questions

How big is the Necrotizing Enterocolitis Market?

The Necrotizing Enterocolitis market was valued at $5.14 billion in 2025, increased to $5.47 billion in 2026, and is projected to reach $6.95 billion by 2030.

What is the Necrotizing Enterocolitis market growth?

The global Necrotizing Enterocolitis market is expected to grow at a CAGR of 6.1% from 2026 to 2035 to reach $6.95 billion by 2035.

Who are the key players in Necrotizing Enterocolitis market?

Some Key Players in the Necrotizing Enterocolitis market Include, Abbott Laboratories, Astellas Pharma Inc., Mayo Foundation for Medical Education and Research, Cleveland Clinic, Boston Children's Hospital, Hollister Incorporated, UPMC Children's Hospital of Pittsburgh, Prolacta Bioscience Inc., Evolve BioSystems, Sigma-Tau Pharmaceuticals, Mead Johnson & Company LLC, Liminal BioSciences Inc., Noveome Biotherapeutics Inc., Infant Bacterial Therapeutics, Prometic Life Sciences Inc., Nexilico, Siolta Therapeutics, ProThera Biologics Inc., Plakous Therapeutics Inc., Chosen Diagnostics Inc. .

What is the anticipated growth trend for the Necrotizing Enterocolitis market?

Major trend in this market includes: Advancements In Innovative Treatments For Necrotizing Enterocolitis In Premature Infants. For further insights on this market. request a sample here

Which region has the most growth potential in the Necrotizing Enterocolitis market?

North America was the largest region in the necrotizing enterocolitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the necrotizing enterocolitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.